E2 ModerateModerate confidencePEM unclearCase-ControlPeer-reviewedMachine draft
Chronic Fatigue Syndrome and DNA Hypomethylation of the Glucocorticoid Receptor Gene Promoter 1F Region: Associations With HPA Axis Hypofunction and Childhood Trauma.
Vangeel, Elise, Van Den Eede, Filip, Hompes, Titia et al. · Psychosomatic medicine · 2015 · DOI
Quick Summary
This study looked at a chemical marker called DNA methylation on a gene (NR3C1) that controls how the body responds to stress. Researchers found that people with ME/CFS had lower levels of this methylation compared to healthy people, which may explain why their bodies don't handle stress hormones properly. Interestingly, childhood trauma did not appear to create additional changes in this marker among ME/CFS patients.
Why It Matters
This study provides molecular evidence supporting the long-hypothesized HPA axis dysfunction in ME/CFS, offering a potential biological marker that could aid diagnosis and understanding of disease mechanisms. The findings suggest that altered gene regulation—not trauma exposure—may be the primary driver of HPA abnormalities in CFS, redirecting research focus toward genetic and epigenetic mechanisms rather than purely psychological pathways.
Observed Findings
- NR3C1-1F promoter methylation was significantly lower in CFS patients than in healthy controls, with CpG_1.5 remaining significant after correction for multiple comparisons (adjusted p = 0.0014).
- Within the CFS group, overall methylation and specific CpG sites (CpG_1.5 and CpG_12.13) were positively correlated with salivary cortisol levels after dexamethasone administration.
- No significant differences in NR3C1-1F methylation were found between CFS patients with moderate/severe childhood trauma and those with no/mild trauma.
- The functional association between methylation levels and cortisol suppression supports the HPA axis hypofunction hypothesis in CFS.
Inferred Conclusions
- Female CFS patients demonstrate NR3C1 promoter hypomethylation consistent with enhanced glucocorticoid receptor sensitivity and HPA axis hypofunction.
- The epigenetic alterations in NR3C1 appear to have direct functional relevance to HPA axis dysregulation in CFS.
- Childhood trauma, while a risk factor for CFS, does not appear to exert its effects through altered NR3C1 methylation patterns.
Remaining Questions
- What causes the NR3C1 hypomethylation in CFS—is it genetically determined, acquired during illness, or present from early life?
- Do these methylation patterns differ between male and female CFS patients, and are they consistent across different CFS phenotypes?
What This Study Does Not Prove
This study does not prove that NR3C1 hypomethylation causes ME/CFS; it only shows an association in a cross-sectional design. It cannot establish whether methylation changes are a primary driver of disease or a consequence of chronic illness. The study also does not demonstrate that childhood trauma has no role in CFS development—only that it does not appear to mediate its effects through NR3C1 methylation.
Tags
Symptom:Fatigue
Biomarker:Gene ExpressionBlood Biomarker
Method Flag:Small SampleExploratory OnlySex-Stratified
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →